Testing a new heart procedure for atrial fibrillation
Part of Heart & circulation clinical trials.
This trial tests a new method called pulsed field ablation (PFA) to treat irregular heartbeats (atrial fibrillation) by isolating the veins that carry blood to your heart. It aims to see how well this procedure works and if it's safe for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having your first procedure to treat atrial fibrillation.
- You are 21 years or older and not pregnant.
- You are willing to sign a consent form to participate.
- Your heart must be in a normal rhythm (sinus rhythm) at the time of the procedure.
- You have not had a prior ablation procedure for your heart.
- You are not participating in another study that could interfere with this one.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new method called pulsed field ablation to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to safely stop AF episodes by targeting specific areas in the heart, and may help people with paroxysmal (coming and going) or persistent AF who haven't had this procedure before.
This study tests a new way to find and treat the specific areas in the heart that cause atrial fibrillation to come back. It aims to improve the success of a repeat ablation procedure for people whose previous pulmonary vein isolation did not stop the irregular heartbeats.
This study tests a new type of energy called pulsed field ablation to treat atrial fibrillation, an irregular heartbeat. It aims to see if it is safe and effective for people whose symptoms have not improved with medication.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
This trial tests a new pulsed-field device used during an atrial fibrillation (AF) catheter ablation, aiming to improve safety and effectiveness. It’s for people who have AF and are planning an AF ablation procedure.
This study tests a new way to measure electrical signals in the heart during a procedure called pulmonary vein isolation, which is used to treat atrial fibrillation (an irregular heartbeat). It aims to improve the accuracy of the treatment, which may help your heart stay in a normal rhythm for longer.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.